Contribution of Epithelial Plasticity to Therapy Resistance. J Clin Med

Intracellular delivery of an antibody targeting Gasdermin-B reduces HER2 breast cancer aggressiveness. Clin Cancer Res

Updating the role of obesity and cholesterol in breast cancer. Breast Cancer Res

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer. PNAS

A role for the Tgf-β/Bmp co-receptor Endoglin in the molecular oscillator that regulates the hair follicle cycle

The Ras-related gene ERAS is involved in human and murine breast cancer. Sci Rep

In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines. Carcinogenesis

A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination. Mol Cancer Ther

Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences. Pathobiology

Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer. Cancer Res

Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells. Cell Rep

EMT: Present and future in clinical oncology

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition. Oncogene

Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma. Int J Cancer

LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway. Sci Rep

Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer. J Pathol

Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers. Mod Pathol

The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients. Oncotarget

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer. Oncotarget

Cancer network activity associated with therapeutic response and synergism. Genome Med

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies. EBioMedicine

The homeoprotein SIX1 controls cellular senescence through the regulation of p16INK4A and differentiation-related genes. Oncogene

Biological Effects of Temsirolimus on the mTOR Pathway in Endometrial Carcinoma: A Pharmacodynamic Phase II Study. Int J Gynecol Cancer

Study of breast cancer incidence in patients of lymphangioleiomyomatosis. Breast Cancer Res Treat

Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression. BMC Cancer

Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells. Oncotarget

A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer. Mod Pathol

Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer. J Natl Cancer Inst

EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination. Oncogene

Loss of Snail2 favors skin tumor progression by promoting the recruitment of myeloid progenitors. Carcinogenesis

Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. EMBO J

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. Int J Cancer

Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization. Oncogene

Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT. Int J Cancer

A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Mol Cancer

Sin3b interacts with Myc and decreases Myc levels. J Biol Chem

MicroRNAs as prognostic markers in ovarian cancer. Mol Cell Endocrinol

The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells. Oncotarget

Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res

ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth. Oncogene

Gasdermin-B promotes invasion and metastasis in breast cancer cells. PLoS One

MicroRNA-dependent regulation of transcription in non-small cell lung cancer. PLoS One

LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition. Biol Open

A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition. J Pathol

. E47 and Id1 interplay in epithelial-mesenchymal transition. PLoS One

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis. Hum Pathol

Endometrial carcinoma: molecular alterations involved in tumor development and progression. Oncogene

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell

The EMT signaling pathways in endometrial carcinoma. Clin Transl Oncol

LOXL2 in epithelial cell plasticity and tumor progression. Future Oncol

Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease. Mol Cell Endocrinol

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med

The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells. Oncogene

Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. EMBO Mol Med

A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance. PLoS One

KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. Am J Pathol

The tumor suppressor ING1 contributes to epigenetic control of cellular senescence. Aging Cell

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol Cancer

The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc

Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma. PNAS

Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases. Am J Surg Pathol

Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res

The class I bHLH factors E2-2A and E2-2B regulate EMT. J Cell Sci

Functional characterization of E- and P-cadherin in invasive breast cancer cells. BMC Cancer

Exosome-mimetic nanoplatforms for targeted cancer drug delivery. J Nanobiotechnology

MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways. Oncogene